FAQs

What is Differentation?

Meet Our Team

Samuel Waxman

Associate Scientific
Directors Jonathan Licht
and Ethan Dmitrovsky

Board of Directors

Funded Investigators

External Advisory
Committee

Executive Director
Merle Kailas &
Foundation Staff

Corporate Council

Annual Report

Funded Investigators & Programs

Select an Investigator -------------------- Albert Einstein Dr. Ari Melnick -------------------- Beth Israel Deaconess Medical Center Dr. Benjamin Neel -------------------- Brandeis University Dr. Ruibao Ren -------------------- The Cancer Research Institute, London Dr. Arthur Zelent -------------------- Columbia University Dr. Paul Fisher -------------------- Dartmouth University Dr. Ethan Dmitrovsky -------------------- Jewish General Hospital (Montreal) Dr. Wilson Miller -------------------- Johns Hopkins University Dr. Stephen Baylin -------------------- M.D. Anderson Cancer Center Dr. Reuben Lotan -------------------- Massachusetts General Hospital Dr. Jeffrey Settleman -------------------- Memorial Sloan Kettering Dr. Neal Rosen -------------------- Mount Sinai Medical Center Dr. Doris Germain -------------------- Shanghai Institute of Hematology Dr. Zhu Chen -------------------- University of California – San Francisco Dr. William Weiss -------------------- University of North Carolina – Chapel Hill Dr. Albert Baldwin Dr. Terry Van Dyke -------------------- Weizmann Institute Dr. Yosef Shaul

Dr. Chen is the Vice President of Chinese Academy of Sciences, the Director of the Chinese National Human Genome Center at Shanghai and the Director of the Shanghai Institute of Hematology. He graduated with an M.D. from Shanghai Second Medical University and received his Ph.D. from Hôpital Saint-Louis, Université Paris VII, France. He worked in Dr. Waxman's laboratory to discover the PC2F gene, which is important in leukemia. As Director of the Samuel Waxman Cancer Research Foundation Laboratory in Shanghai, he oversees research developing new cancer specific therapies.

return to top